Cite
HARVARD Citation
Noh, Y. et al. (2019). A safety, pharmacokinetic, pharmacogenomic and population pharmacokinetic analysis of the third‐generation EGFR TKI, olmutinib (HM61713), after single oral administration in healthy volunteers. Basic & clinical pharmacology & toxicology. 125 (4), pp. 370-381. [Online].